Carisoprodol Tablets, Usp, 350 Mg Tablet
Product Images NDC 63561-0127

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Carisoprodol Tablets, Usp, 350 Mg (NDC 63561-0127). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Granulation Technology, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

350 mg Bottle Label-100 Ct. (Cari 350mg 100 Ct.)

350 mg Bottle Label-100 Ct. (Cari 350mg 100 Ct.)
Label for Carisoprodol Tablets, USP, 350 mg, a human prescription oral tablet. The label indicates a package of 100 tablets, with a dosage strength of 350 mg per tablet. Manufactured for Granulation Technology, Inc., Fairfield, NJ. Additional directions, storage instructions, and barcode are also visible.*
FDA Label Image

350 mg Bottle Label-1000 Ct. (Cari 350mg 1000 Ct.)

350 mg Bottle Label-1000 Ct. (Cari 350mg 1000 Ct.)
Label for Carisoprodol Tablets, USP 350 mg, human prescription oral tablets by Granulation Technology, Inc. The label includes the NDC 63561-0127 and indicates a bottle of 1000 tablets. It provides standard storage instructions, dosage guidance referencing the package insert, and a barcode.*
FDA Label Image

Carisoprodol Structural Formula (Cari Stru.)

Carisoprodol Structural Formula (Cari Stru.)
Chemical structure of carisoprodol, displaying its molecular arrangement with labeled functional groups typical for this muscle relaxant.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.